Solventum Corporation SOLV

89.50 0.91 1.03% as of 25 Sep
Market cap
$15.1B
P/E
10.9×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Solventum Corporation (SOLV) P/S ratio

As of 25 September 2026, Solventum Corporation (SOLV) trades at a P/S ratio of 1.9×. Over the past ten years it has ranged from 1.0× (July 2024) to 1.9× (September 2026); the current reading is higher than 98% of that period. That is below the Medical Instruments & Supplies industry median of 2.8× and below the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 1.7× 19.54%
FY2024 1.4× (17.76%)
FY2023 1.7× 0.00%
FY2022 1.7× —

Quarterly

Period P/S ratio Change
Jun 2026 1.6× 16.45%
Mar 2026 1.4× (16.92%)
Dec 2025 1.7× 9.42%
Sep 2025 1.5× (3.79%)
10 more quarters

Against its own ten years

Low 1.0× High 1.9×
Ten-year median 1.5×
Current reading's percentile 98

P/S ratio against peers

Company P/S ratio
BAX Baxter International Inc. compare 1.1×
AVTR Avantor, Inc. compare 1.6×
SOLV Solventum Corporation 1.9×
ATR AptarGroup, Inc. compare 2.0×
COO The Cooper Companies, Inc. compare 2.5×
ALGN Align Technology, Inc. compare 2.5×
ALC Alcon compare 2.9×
WST West Pharmaceutical Services, Inc. compare 7.9×
RGEN Repligen Corporation compare 13.6×
Medical Instruments & Supplies industry median 2.8×
Healthcare sector median 3.8×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on SOLV